Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Cardiovascular & Hematological Agents in Medicinal Chemistry|December 3, 2013
Serelaxin: new investigational treatment in acute heart failureSarmad Said, Debabrata MukherjeeCardiovascular & Hematological Agents in Medicinal Chemistry|September 13, 2013
Sodium glucose co-transporter 2 (SGLT2) inhibition with canagliflozin in type 2 diabetes mellitusSarmad Said, German T HernandezAdvances in Chronic Kidney Disease|January 10, 2015
Environmental exposures, socioeconomics, disparities, and the kidneysSarmad Said, German T HernandezJournal of Nephropathology|August 6, 2014
The link between chronic kidney disease and cardiovascular diseaseSarmad Said, German T HernandezNeurology International|July 3, 2014
West nile virus encephalitis induced opsoclonus-myoclonus syndromeChad J Cooper, Sarmad SaidCurrent Vascular Pharmacology|July 27, 2016
Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular RiskSarmad Said, Debabrata Mukherjee, Thomas F WhayneCardiovascular & Hematological Agents in Medicinal Chemistry|March 14, 2018
Entresto, a New Panacea for Heart Failure?Peter Khalil, Ghazal Kabbach, Sarmad Said, et al.Case Reports in Immunology|November 8, 2014
Recurrent Skin and Lung Infections in Autosomal Dominant Hyper IgE Syndrome with Transactivation Domain STAT3 MutationChad J Cooper, Sarmad Said, German T HernandezCardiovascular & Hematological Disorders Drug Targets|July 5, 2014
Alogliptin; a review of a new dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type 2 diabetes mellitusSarmad Said, Azikiwe C Nwosu, Debabrata Mukherjee, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|March 25, 2014
Eisenmenger syndrome: recent advances in pharmacotherapySarmad Said, Mateo Porres-Aguilar, Mateo Porres-Munoz, et al.Pageof 5